Avara Pharmaceutical Services Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11101
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical ingredients (API), packaging, process scale-up and optimization and multi-purpose equipment and facility designs, and blending among others. Avara spans its expertise in tablet printing, capsule filling, fluid bed granulation, spray drying, product release testing, stability storage and testing and CTM packaging in bottles and blisters. The company caters its services to the pharmaceutical industry. Avara is located in Norwalk, Connecticut, the US.

Avara Pharmaceutical Services Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Avara Pharmaceutical Services Acquires Sterile Manufacturing Facility and Development Center from Novartis 10
Avara Pharma Acquires Reims Manufacturing Facility from AstraZeneca 11
Avara Pharma to Acquire Consumer Healthcare Manufacturing Facility from GlaxoSmithKline 12
Avara Pharma to Acquire Sterile Manufacturing from Pfizer 13
Avara Pharma Acquires Manufacturing Facility from AstraZeneca 14
Acquisition 15
Avara Pharma Acquires Astellas Pharma Technologies from Astellas US Holding 15
Avara Pharmaceutical Services Inc – Key Competitors 16
Avara Pharmaceutical Services Inc – Key Employees 17
Avara Pharmaceutical Services Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Key Facts 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avara Pharmaceutical Services Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avara Pharmaceutical Services Acquires Sterile Manufacturing Facility and Development Center from Novartis 10
Avara Pharma Acquires Reims Manufacturing Facility from AstraZeneca 11
Avara Pharma to Acquire Consumer Healthcare Manufacturing Facility from GlaxoSmithKline 12
Avara Pharma to Acquire Sterile Manufacturing from Pfizer 13
Avara Pharma Acquires Manufacturing Facility from AstraZeneca 14
Avara Pharma Acquires Astellas Pharma Technologies from Astellas US Holding 15
Avara Pharmaceutical Services Inc, Key Competitors 16
Avara Pharmaceutical Services Inc, Key Employees 17
Avara Pharmaceutical Services Inc, Other Locations 18
Avara Pharmaceutical Services Inc, Subsidiaries 18

List of Figures
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Avara Pharmaceutical Services Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Packages Limited:企業の戦略・SWOT・財務情報
    Packages Limited - Strategy, SWOT and Corporate Finance Report Summary Packages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ferndale Pharma Group Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferndale Pharma Group Inc (Ferndale Pharma), formerly Ferndale Laboratories Inc is a manufacturer and distributor of pharmaceutical products. The company provides surgical instruments, medical supplies, skin care products, topical therapeutic products, prescription, over the counter products …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • ORChem Co., Ltd.:企業のM&A・事業提携・投資動向
    ORChem Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORChem Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Zagro Asia Ltd:企業の戦略的SWOT分析
    Zagro Asia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Norfolk Southern Corporation:企業の戦略・SWOT・財務情報
    Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report Summary Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • FTS International Services, LLC-石油・ガス分野:企業M&A・提携分析
    Summary FTS International Services, LLC (FTSI) is a private oilfield services company. It provides a well completion services, including pressure pumping, wireline and reservoir optimization technologies. The company offers products and services to the exploration and production companies to enhance …
  • Medigus Ltd (MDGS):企業の財務・戦略的SWOT分析
    Summary Medigus Ltd (Medigus) is a medical device company that develops, produces and markets endoscopic surgical devices for minimally invasive medical procedures. The company flagship product, Medigus ultrasonic surgical endostapler (MUSE) system, a comprehensive endoscopic device for the treatmen …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務分析
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Inogen Inc (INGN):企業の財務・戦略的SWOT分析
    Summary Inogen Inc (Inogen) is a medical device company that offers oxygen therapy technology solutions. The company offers products which include g2 portable oxygen concentrator system, g3 portable oxygen concentrator system, home oxygen concentrator and accessory items. Its products are used in bo …
  • Daiichi Sankyo Co Ltd (4568):医療機器:M&Aディール及び事業提携情報
    Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompa …
  • Genzyme Corp:企業の戦略的SWOT分析
    Genzyme Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Magnis Resources Limited (MNS):企業の財務・戦略的SWOT分析
    Magnis Resources Limited (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rashtriya Chemicals and Fertilizers Ltd (RCF):企業の財務・戦略的SWOT分析
    Summary Rashtriya Chemicals and Fertilizers Ltd (RCFL) is a chemical company that manufactures and markets fertilizers and industrial chemicals. The company offers industrial chemicals include methanol, mono methylamine, strong nitric acid, dilute nitric acid, sulphuric acid, sodium nitrite, anhydro …
  • QCR Holdings, Inc.:企業のM&A・事業提携・投資動向
    QCR Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QCR Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • TransAtlantic Petroleum Ltd (TAT):石油・ガス:M&Aディール及び事業提携情報
    Summary TransAtlantic Petroleum Ltd. (TransAtlantic) is an upstream energy company that acquires, develops, explores for, and produces crude oil and natural gas. It holds interests in developed and undeveloped oil and natural gas properties in Turkey and Bulgaria. The company operates onshore explor …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. Its ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to the neuropil …
  • GlaxoSmithKline Plc (GSK)-医療機器分野:企業M&A・提携分析
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respira …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆